Online citations, reference lists, and bibliographies.
← Back to Search

Specificity Of The American Urological Association Voiding Symptom Index: Comparison Of Unselected And Selected Samples Of Both Sexes.

T. Chai, W. Belville, E. Mcguire, L. Nyquist
Published 1993 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The American Urological Association voiding symptom index questionnaire for benign prostatic hypertrophy was administered to an elderly unselected sample and a selected urology clinic sample of both sexes to investigate the ability of this instrument to identify prostatic pathological conditions. The female subjects in these cohorts provided a control. In the large unselected sample the male subjects scored statistically higher in only 2 categories, weak stream (487 subjects) and strain (507) (p < 0.05 for both categories). The clinical significance of these scores is questionable, however, since they were low (less than 2 of 5). In the selected group (145 subjects) the female subjects showed a higher total mean score due to the contribution of statistically higher irritative scores (p < 0.05). We conclude that the American Urological Association voiding symptom index does not specifically identify prostatic pathological conditions, and that elderly men and women have similar voiding symptom scores. Therefore, treatment that results in improvement in symptom scores may not specifically affect the prostate. Other factors, such as an aging detrusor, changes in physiological production of urine or other unknown factors, may contribute to the symptoms.
This paper references
10.1016/S0022-5347(17)39374-6
Endoscopic balloon dilation of the prostate: early experience.
S. Goldenberg (1990)
10.1016/S0022-5347(17)54140-3
High flow infravesical obstruction in men: symptomatology, urodynamics and the results of surgery.
T. Gerstenberg (1982)
10.1016/0090-4295(88)90461-X
Diagnosis and grading of outflow obstruction.
Z. Khan (1988)
Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
J. Blaivas (1988)
10.1148/RADIOLOGY.177.2.1699247
Experimental treatment of benign prostatic hyperplasia with transurethral balloon dilation of the prostate: preliminary study in 73 humans.
N. Wasserman (1990)
10.1016/S0022-5347(17)52351-4
The relevance of minimum urethral resistance in prostatism.
R. Bruskewitz (1983)
10.1111/J.1464-410X.1937.TB06620.X
THE PROSTATE AND THE ENDOCRINES: A Control Series*
R. Clarke (1937)
10.1016/s0022-5347(17)36966-5
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.
M. Barry (1992)
10.1002/J.1939-4640.1991.TB00288.X
A permanent, epithelializing stent for the treatment of benign prostatic hyperplasia. Preliminary results.
J. Oesterling (1991)
10.1056/NEJM199210223271701
The effect of finasteride in men with benign prostatic hyperplasia.
P. Walsh (1993)
10.1016/S0022-5347(17)39620-9
Use of an α1-Blocker, YM617, in the Treatment of Benign Prostatic Hypertrophy
K. Kawabe (1990)
Proceedings: The value of urodynamics in the differential diagnosis of urinary outflow tract obstruction.
Buck Ac (1974)
10.1016/0140-6736(91)93140-5
Alfuzosin for treatment of benign prostatic hypertrophy
A. Jardin (1991)
10.1111/J.1464-410X.1992.TB15631.X
Laser ablation of the prostate in patients with benign prostatic hypertrophy.
A. Costello (1992)
10.1016/0090-4295(76)90560-4
Natural history of benign prostatic hypertrophy and acute urinary retention.
J. Birkhoff (1976)
10.1016/S0022-5347(17)37624-3
The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.
H. Lepor (1992)
10.1159/000280194
The Significance of the Symptoms Associated with Bladder Outflow Obstruction
P. Abrams (1978)
10.1016/S0022-5347(17)49587-5
Analysis of presenting symptoms in prostatism.
P. C. Frimodt-Møller (1984)



This paper is referenced by
10.1016/J.EJPHAR.2004.06.066
Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia.
A. Ohtake (2004)
10.1007/PL00014136
Epidemiology and etiology of urinary incontinence in the elderly
C. McGrother (1998)
10.1007/978-90-313-6614-9_46
NHG-Standaard Bemoeilijkte mictie bij oudere mannen
R. Wolters (2009)
10.1007/S11884-009-0025-Z
Overlap of voiding symptoms among common urologic conditions
J. Clemens (2009)
10.1002/NAU.20022
Degree of bother caused by nocturia in women
J. Fiske (2004)
10.1016/J.JMHG.2005.01.007
Men's bladder health: urinary incontinence in the elderly (Part I)
H. Madersbacher (2005)
10.1007/S001310050362
Epidemiologie und Ätiologie der Harninkontinenz im Alter
E. J. Mcguire (1998)
10.4111/KJU.2006.47.2.165
Urodynamic Analysis of Taxi Drivers with Lower Urinary Tract Symptoms
S. Kim (2006)
10.1007/s00192-004-1197-x
Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings
N. Rosenblum (2004)
10.1093/FAMPRA/18.3.328
Questioning questions about symptoms of benign prostatic hyperplasia.
E. Hassler (2001)
10.1002/NAU.20189
Normative values for the American Urological Association Symptom Index (AUA‐7) and short form Urogenital Distress Inventory (UDI‐6) in patients 65 and older presenting for non‐urological care
R. Svatek (2005)
10.1002/nau.22237
Bladder dysfunction in advanced Parkinson's disease
K. Winge (2012)
10.1016/S0022-5347(01)65480-6
A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography.
O. Ukimura (1996)
10.1016/S0090-4295(99)80084-3
Randomized clinical trial comparing low power-slow heating versus high power-rapid heating noncontact neodymium:yttrium-aluminum-garnet laser regimens for the treatment of benign prostatic hyperplasia.
E. Orihuela (1995)
10.1016/S0022-5347(05)67048-6
Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms.
I. Araki (2000)
10.1111/j.1442-2042.2009.02442.x
Lower urinary tract symptoms in women with irritable bowel syndrome
Yajun Guo (2010)
10.1111/j.1464-410X.2006.06574.x
The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta‐analysis
B. Blake-James (2007)
10.1002/nau.20772
Edward McGuire's influence in the field of stress urinary incontinence and bladder storage symptoms
T. Chai (2010)
10.17037/PUBS.00682257
Assessing health care need for prostatectomy.
D. Hunter (1995)
10.1007/s00415-002-0775-4
Relationship between urinary symptoms and disease-related parameters in multiple sclerosis
I. Araki (2002)
10.1016/S0090-4295(97)00717-6
Health-related quality of life associated with lower urinary tract symptoms in four countries.
C. Girman (1998)
10.1001/ARCHINTE.166.21.2381
Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.
V. Kupelian (2006)
10.1007/8904_2015_414
Bladder and Bowel Dysfunction Is Common in Both Men and Women with Mutation of the ABCD1 Gene for X-Linked Adrenoleukodystrophy.
J. Hofereiter (2015)
10.1016/j.juro.2017.10.035
Baseline Lower Urinary Tract Symptoms in Patients Enrolled in LURN: A Prospective, Observational Cohort Study
A. Cameron (2018)
10.1177/014572170202800312
Nocturnal Polyuria in Type 2 Diabetes: A Symptom of Obstructive Sleep Apnea
E. Chasens (2002)
Outcomes of Midurethral Slings in Women with Concomitant Preoperative Severe Lower Urinary Tract Voiding Symptoms.
Michael S. Ingber (2015)
10.1007/S11934-002-0047-Y
Medical therapy for benign prostatic hyperplasia progression
K. McVary (2002)
10.3945/jn.110.132514
Dietary, but not supplemental, intakes of carotenoids and vitamin C are associated with decreased odds of lower urinary tract symptoms in men.
Nancy N. Maserejian (2011)
10.7024/JUAROC.200012.0161
Lower Urinary Tract Symptoms in Women with Systemic Lupus Erythematosus
Wei-Chia Lee (2000)
10.1002/(SICI)1520-6777(1999)18:3<173::AID-NAU3>3.0.CO;2-M
The international prostate symptom score in both sexes: A urodynamics‐based comparison
S. Madersbacher (1999)
10.1007/978-1-59259-644-7_4
Urodynamics and the Evaluation of Male Lower Urinary Tract Symptoms
J. Clemens (2004)
10.1093/aje/kws411
Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women.
N. Maserejian (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar